Back to ABTABBOTT LABORATORIES (ABT)View full pipeline
(9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400
Phase 2Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Adalimumab every other weekPhase 3
Plaque Psoriasis
Adalimumab Every WeekPhase 3
Plaque Psoriasis
Levodopa-carbidopa intestinal gelPhase 3
Dyskinesias
DivalproexPhase 3
Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania
Leuprolide acetate - Formulation BPhase 3
Prostate Cancer
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts